JP2008529745A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008529745A5 JP2008529745A5 JP2007556360A JP2007556360A JP2008529745A5 JP 2008529745 A5 JP2008529745 A5 JP 2008529745A5 JP 2007556360 A JP2007556360 A JP 2007556360A JP 2007556360 A JP2007556360 A JP 2007556360A JP 2008529745 A5 JP2008529745 A5 JP 2008529745A5
- Authority
- JP
- Japan
- Prior art keywords
- polymer
- poly
- analog
- drug
- lactone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65417505P | 2005-02-18 | 2005-02-18 | |
| US60/654,175 | 2005-02-18 | ||
| PCT/US2006/005799 WO2006089207A2 (en) | 2005-02-18 | 2006-02-21 | Drugs with improved hydrophobicity for incorporation in medical devices |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012202097A Division JP5566431B2 (ja) | 2005-02-18 | 2012-09-13 | 医療装置に結合した改善された疎水性を有した薬剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008529745A JP2008529745A (ja) | 2008-08-07 |
| JP2008529745A5 true JP2008529745A5 (cg-RX-API-DMAC10.html) | 2008-11-27 |
| JP5139814B2 JP5139814B2 (ja) | 2013-02-06 |
Family
ID=36917120
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007556360A Expired - Lifetime JP5139814B2 (ja) | 2005-02-18 | 2006-02-21 | 医療装置に結合した改善された疎水性を有した薬剤 |
| JP2012202097A Expired - Lifetime JP5566431B2 (ja) | 2005-02-18 | 2012-09-13 | 医療装置に結合した改善された疎水性を有した薬剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012202097A Expired - Lifetime JP5566431B2 (ja) | 2005-02-18 | 2012-09-13 | 医療装置に結合した改善された疎水性を有した薬剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US20090130163A1 (cg-RX-API-DMAC10.html) |
| EP (4) | EP3345631A1 (cg-RX-API-DMAC10.html) |
| JP (2) | JP5139814B2 (cg-RX-API-DMAC10.html) |
| CN (5) | CN105879114A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2006214100B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2598213C (cg-RX-API-DMAC10.html) |
| ES (1) | ES2663495T3 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2006089207A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7550608B2 (en) * | 2005-06-10 | 2009-06-23 | Florida State University Research Foundation, Inc. | Processes for the preparation of docetaxel |
| AU2006258065A1 (en) | 2005-06-10 | 2006-12-21 | Florida State University Research Foundation, Inc. | Processes for the production of polycyclic fused ring compounds |
| EP1976505A1 (en) * | 2005-11-14 | 2008-10-08 | Abraxis BioScience, Inc. | Combretastatin derivatives and related therapeutic methods |
| PE20081506A1 (es) | 2006-12-12 | 2008-12-09 | Infinity Discovery Inc | Formulaciones de ansamicina |
| EP3417859A1 (en) | 2007-03-07 | 2018-12-26 | Abraxis BioScience, LLC | Nanoparticle comprising rapamycin and albumin as anticancer agent |
| WO2008137148A2 (en) | 2007-05-03 | 2008-11-13 | Abraxis Bioscience, Llc | Methods and compositions for treating pulmonary hypertension |
| AU2008260447B2 (en) | 2007-06-01 | 2013-10-10 | Abraxis Bioscience, Llc | Methods and compositions for treating recurrent cancer |
| CA2721153C (en) * | 2008-04-10 | 2018-10-02 | Abraxis Bioscience, Llc | Compositions of hydrophobic taxane derivatives and uses thereof |
| WO2009126175A1 (en) * | 2008-04-10 | 2009-10-15 | Abraxis Bioscience, Llc | Compositions of hydrophobic taxane derivatives and uses thereof |
| MX2011010673A (es) * | 2009-04-10 | 2012-02-21 | Abraxis Bioscience Llc | Formulaciones de nanoparticulas y usos de las mismas. |
| EP2447268A1 (en) | 2010-10-29 | 2012-05-02 | INDENA S.p.A. | Crystalline form of 13-[(N-tert-butoxycarbonyl)-2'-O-hexanoyl-3-phenylisoserinyl]-10-deacetylbaccatin III |
| CN102649795B (zh) * | 2011-06-23 | 2014-08-06 | 东北林业大学 | 10-甲氧基喜树碱衍生物、制备方法和用途 |
| US9610385B2 (en) * | 2013-03-07 | 2017-04-04 | Abbott Cardiovascular Systems Inc. | Method of fabricating an implantable medical device comprising a rapamycin derivative |
| EP2924022A1 (en) * | 2014-03-27 | 2015-09-30 | INDENA S.p.A. | Amorphous form of a thiocolchicine derivative |
| US10527604B1 (en) * | 2015-03-05 | 2020-01-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel |
| US10705070B1 (en) | 2015-03-05 | 2020-07-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug |
| CN106236752A (zh) * | 2016-07-29 | 2016-12-21 | 浙江大学 | 联合用药抗肿瘤药物、制备方法及应用 |
| CN106242972B (zh) * | 2016-07-29 | 2019-02-26 | 浙江大学 | 康普瑞汀药物前体、药物制剂和制备方法 |
| AU2019239953B2 (en) | 2018-03-20 | 2025-01-02 | Abraxis Bioscience, Llc | Methods of treating central nervous system disorders via administration of nanoparticles of an mtor inhibitor and an albumin |
| KR20210024471A (ko) | 2018-05-22 | 2021-03-05 | 아브락시스 바이오사이언스, 엘엘씨 | 폐고혈압을 치료하기 위한 방법 및 조성물 |
| IL292439B2 (en) | 2019-10-28 | 2026-05-01 | Abraxis Bioscience Llc | Pharmaceutical preparations of albumin and rapamycin |
| EP4188335A2 (en) * | 2020-07-29 | 2023-06-07 | Biotronik Ag | Pharmaceutical microsphere compositions and methods |
Family Cites Families (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4141087A (en) | 1977-01-19 | 1979-02-27 | Ethicon, Inc. | Isomorphic copolyoxalates and sutures thereof |
| US4208511A (en) | 1977-01-19 | 1980-06-17 | Ethicon, Inc. | Isomorphic copolyoxalates and sutures thereof |
| US4105034A (en) | 1977-06-10 | 1978-08-08 | Ethicon, Inc. | Poly(alkylene oxalate) absorbable coating for sutures |
| US4205399A (en) * | 1977-06-13 | 1980-06-03 | Ethicon, Inc. | Synthetic absorbable surgical devices of poly(alkylene oxalates) |
| US4140678A (en) * | 1977-06-13 | 1979-02-20 | Ethicon, Inc. | Synthetic absorbable surgical devices of poly(alkylene oxalates) |
| US4130639A (en) | 1977-09-28 | 1978-12-19 | Ethicon, Inc. | Absorbable pharmaceutical compositions based on isomorphic copolyoxalates |
| US4261989A (en) * | 1979-02-19 | 1981-04-14 | Kaken Chemical Co. Ltd. | Geldanamycin derivatives and antitumor drug |
| US4316885A (en) * | 1980-08-25 | 1982-02-23 | Ayerst, Mckenna And Harrison, Inc. | Acyl derivatives of rapamycin |
| US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
| US4800882A (en) | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
| US4886062A (en) | 1987-10-19 | 1989-12-12 | Medtronic, Inc. | Intravascular radially expandable stent and method of implant |
| US5171217A (en) * | 1991-02-28 | 1992-12-15 | Indiana University Foundation | Method for delivery of smooth muscle cell inhibitors |
| US5319112A (en) * | 1992-08-18 | 1994-06-07 | Virgnia Tech Intellectual Properties, Inc. | Method for the conversion of cephalomannine to taxol and for the preparation of N-acyl analogs of taxol |
| US5262423A (en) * | 1992-10-29 | 1993-11-16 | American Home Products Corporation | Rapamycin arylcarbonyl and alkoxycarbonyl carbamates as immunosuppressive and antifungal agents |
| IL107950A (en) * | 1992-12-15 | 2001-04-30 | Upjohn Co | 7β, 8β - METHANO-TAXOLS, THEIR PREPARATION AND ANTINEOPLASTIC PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| US5468253A (en) | 1993-01-21 | 1995-11-21 | Ethicon, Inc. | Elastomeric medical device |
| US5580899A (en) * | 1995-01-09 | 1996-12-03 | The Liposome Company, Inc. | Hydrophobic taxane derivatives |
| US5618552A (en) | 1995-03-06 | 1997-04-08 | Ethicon, Inc. | Absorbable polyoxaesters |
| US5597579A (en) | 1995-03-06 | 1997-01-28 | Ethicon, Inc. | Blends of absorbable polyoxaamides |
| US5700583A (en) | 1995-03-06 | 1997-12-23 | Ethicon, Inc. | Hydrogels of absorbable polyoxaesters containing amines or amido groups |
| US5464929A (en) | 1995-03-06 | 1995-11-07 | Ethicon, Inc. | Absorbable polyoxaesters |
| US5698213A (en) | 1995-03-06 | 1997-12-16 | Ethicon, Inc. | Hydrogels of absorbable polyoxaesters |
| US5607687A (en) | 1995-03-06 | 1997-03-04 | Ethicon, Inc. | Polymer blends containing absorbable polyoxaesters |
| US5648088A (en) * | 1995-03-06 | 1997-07-15 | Ethicon, Inc. | Blends of absorbable polyoxaesters containing amines and/or amide groups |
| US5595751A (en) | 1995-03-06 | 1997-01-21 | Ethicon, Inc. | Absorbable polyoxaesters containing amines and/or amido groups |
| TW354293B (en) * | 1995-06-06 | 1999-03-11 | Bristol Myers Squibb Co | Prodrugs of paclitaxel derivatives |
| DK1229030T3 (da) * | 1995-09-12 | 2006-02-13 | Zeneus Pharma Ltd | Hydrolysefremmende, hydrofobe taxanderivater |
| US6107332A (en) * | 1995-09-12 | 2000-08-22 | The Liposome Company, Inc. | Hydrolysis-promoting hydrophobic taxane derivatives |
| US7445792B2 (en) * | 2003-03-10 | 2008-11-04 | Abbott Laboratories | Medical device having a hydration inhibitor |
| US20030040790A1 (en) * | 1998-04-15 | 2003-02-27 | Furst Joseph G. | Stent coating |
| US6153252A (en) * | 1998-06-30 | 2000-11-28 | Ethicon, Inc. | Process for coating stents |
| US7455853B2 (en) * | 1998-09-24 | 2008-11-25 | Abbott Cardiovascular Systems Inc. | Medical devices containing rapamycin analogs |
| US6258121B1 (en) * | 1999-07-02 | 2001-07-10 | Scimed Life Systems, Inc. | Stent coating |
| WO2001054745A2 (en) * | 2000-01-25 | 2001-08-02 | Edwards Lifesciences Corporation | Bioactive coatings to prevent tissue overgrowth on artificial heart valves |
| EP1261337B1 (en) * | 2000-02-28 | 2008-09-10 | The University Of British Columbia | Topoisomerase inhibitors for treatment of surgical adhesions |
| IT1318401B1 (it) * | 2000-03-17 | 2003-08-25 | Indena Spa | Derivati di n-desacetiltiocolchicina e composizioni farmaceutiche cheli contengono. |
| US6723373B1 (en) * | 2000-06-16 | 2004-04-20 | Cordis Corporation | Device and process for coating stents |
| US20020127263A1 (en) * | 2001-02-27 | 2002-09-12 | Wenda Carlyle | Peroxisome proliferator-acitvated receptor gamma ligand eluting medical device |
| EP1647289A1 (en) * | 2001-02-27 | 2006-04-19 | Medtronic Vascular, Inc. | Peroxisome proliferator-activated receptor gamma ligand eluting medical device |
| US7771468B2 (en) * | 2001-03-16 | 2010-08-10 | Angiotech Biocoatings Corp. | Medicated stent having multi-layer polymer coating |
| GB0122393D0 (en) * | 2001-09-17 | 2001-11-07 | Polybiomed Ltd | Treating metal surfaces to enhance bio-compatibility |
| JP2005504086A (ja) * | 2001-09-24 | 2005-02-10 | コンフォーマ セラピューティクス コーポレーション | 17−アリルアミノゲルダナマイシン(17−aag)および他のアンサマイシン類を製造する方法 |
| US20030065382A1 (en) * | 2001-10-02 | 2003-04-03 | Fischell Robert E. | Means and method for the treatment of coronary artery obstructions |
| DK1435877T3 (da) * | 2001-10-15 | 2009-08-03 | Hemoteq Ag | Overtrækning af stents for at forhindre restenose |
| EP1465618A2 (en) * | 2001-12-20 | 2004-10-13 | Bristol-Myers Squibb Company | Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability |
| EP1485042A1 (en) * | 2002-03-18 | 2004-12-15 | Medtronic AVE Inc. | Medical devices for delivering anti-proliferative compositions to anatomical sites at risk of restenosis |
| US7176325B2 (en) * | 2002-04-05 | 2007-02-13 | Natural Pharmaceuticals, Inc. | Selective acylation of secondary hydroxyl groups |
| EP1501565B1 (de) * | 2002-05-09 | 2006-11-02 | Hemoteq GmbH | Verbindungen und verfahren zur hemokompatiblen beschichtung von oberflächen |
| CN1655738A (zh) * | 2002-05-20 | 2005-08-17 | 奥勃斯医学技术股份有限公司 | 可植入的药物洗脱医疗装置 |
| CN101134119A (zh) * | 2002-05-24 | 2008-03-05 | 血管技术国际股份公司 | 用于涂覆医用植入物的组合物和方法 |
| CN100363366C (zh) * | 2002-06-27 | 2008-01-23 | 中国科学院上海药物研究所 | 一类喜树碱衍生物及制备方法 |
| AU2003280437A1 (en) * | 2002-06-27 | 2004-01-19 | Microport Medical (Shanghai) Co., Ltd. | Drug eluting stent |
| WO2004009147A1 (en) * | 2002-07-18 | 2004-01-29 | Medtronic Ave Inc. | Medical devices comprising a protein-tyrosine kinase inhibitor to inhibit restonosis |
| US6991617B2 (en) | 2002-08-21 | 2006-01-31 | Hektner Thomas R | Vascular treatment method and device |
| DE10244847A1 (de) * | 2002-09-20 | 2004-04-01 | Ulrich Prof. Dr. Speck | Medizinische Vorrichtung zur Arzneimittelabgabe |
| CA2508831C (en) * | 2002-12-13 | 2012-05-01 | Immunomedics, Inc. | Immunoconjugates with an intracellularly-cleavable linkage |
| US20040236415A1 (en) * | 2003-01-02 | 2004-11-25 | Richard Thomas | Medical devices having drug releasing polymer reservoirs |
| US20040167572A1 (en) * | 2003-02-20 | 2004-08-26 | Roth Noah M. | Coated medical devices |
| US20040236290A1 (en) * | 2003-04-23 | 2004-11-25 | Zimmermann Stephan A. | Minimally invasive vascular apparatus modified to minimize scarring at introduction site |
| US20050033417A1 (en) * | 2003-07-31 | 2005-02-10 | John Borges | Coating for controlled release of a therapeutic agent |
| US20060024357A1 (en) * | 2004-05-12 | 2006-02-02 | Medivas, Llc | Wound healing polymer compositions and methods for use thereof |
| US20050158356A1 (en) * | 2003-11-20 | 2005-07-21 | Angiotech International Ag | Implantable sensors and implantable pumps and anti-scarring agents |
| WO2005062985A2 (en) * | 2003-12-23 | 2005-07-14 | American Bioscience, Inc. | Di-ester prodrugs of camptothecin, process for their preparation and their therapeutical applications |
| ITMI20040164A1 (it) * | 2004-02-03 | 2004-05-03 | Indena Spa | Derivati di n.deacetiltiocolchicina loro uso e formulazioni farmaceutiche che li contengono |
-
2006
- 2006-02-21 EP EP18151265.8A patent/EP3345631A1/en not_active Withdrawn
- 2006-02-21 WO PCT/US2006/005799 patent/WO2006089207A2/en not_active Ceased
- 2006-02-21 JP JP2007556360A patent/JP5139814B2/ja not_active Expired - Lifetime
- 2006-02-21 CN CN201610206128.2A patent/CN105879114A/zh active Pending
- 2006-02-21 CN CN201310051405.3A patent/CN103143069B/zh not_active Expired - Fee Related
- 2006-02-21 ES ES06720876.9T patent/ES2663495T3/es not_active Expired - Lifetime
- 2006-02-21 CN CN201410551109.4A patent/CN104667355A/zh active Pending
- 2006-02-21 EP EP06720876.9A patent/EP1861070B1/en not_active Expired - Lifetime
- 2006-02-21 CA CA2598213A patent/CA2598213C/en not_active Expired - Lifetime
- 2006-02-21 US US11/816,307 patent/US20090130163A1/en not_active Abandoned
- 2006-02-21 EP EP18151341.7A patent/EP3345632A1/en not_active Withdrawn
- 2006-02-21 CN CN2006800090730A patent/CN101146514B/zh not_active Expired - Fee Related
- 2006-02-21 AU AU2006214100A patent/AU2006214100B2/en not_active Ceased
- 2006-02-21 CN CN201610206288.7A patent/CN105688289A/zh active Pending
- 2006-02-21 EP EP15000183.2A patent/EP2896412A1/en not_active Withdrawn
-
2012
- 2012-09-13 JP JP2012202097A patent/JP5566431B2/ja not_active Expired - Lifetime
-
2015
- 2015-03-20 US US14/664,359 patent/US20150190556A1/en not_active Abandoned
-
2017
- 2017-03-31 US US15/476,482 patent/US20170203012A1/en not_active Abandoned
-
2018
- 2018-07-02 US US16/025,671 patent/US20180318473A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2543330C2 (ru) | Баллонный катетер, покрытый антирестенозным активным ингредиентом и молекулярный диспергирующий агент, способствующий переносу | |
| JP6134788B2 (ja) | 疎水性組成物のための生分解性薬物送達 | |
| CA2598213A1 (en) | Drugs with improved hydrophobicity for incorporation in medical devices | |
| JP5615173B2 (ja) | 高度に揮発性のシリコーンを含有する医薬製剤 | |
| CN113226389B (zh) | 在经改性设备表面上具有药物洗脱涂层的医疗设备 | |
| JP2009504763A5 (cg-RX-API-DMAC10.html) | ||
| JP6174038B2 (ja) | 薬剤被覆された医療機器およびその調整方法 | |
| JP2005512959A5 (cg-RX-API-DMAC10.html) | ||
| EP1832289A3 (en) | Compositions and coatings for implantable medical devices | |
| JP2011530597A5 (cg-RX-API-DMAC10.html) | ||
| ES2894112T3 (es) | Nanopartículas que contienen tacrolimus | |
| RS56550B1 (sr) | Biorazgradivi sastavi za isporuku lekova | |
| JP2009502355A5 (cg-RX-API-DMAC10.html) | ||
| GB0814302D0 (en) | Compounds and methods | |
| CN102526861A (zh) | 一种介入医疗器械 | |
| WO2007058190A1 (ja) | 薬剤放出制御組成物および薬剤放出性医療器具 | |
| JP2008512411A5 (cg-RX-API-DMAC10.html) | ||
| JP5006261B2 (ja) | 薬物放出ステント用コーティング剤、その製造方法、および前記コーティング剤でコートされた薬物放出ステント | |
| PT1453487E (pt) | Forma de dosagem farmacêutica com revestimentos múltiplos | |
| JP2008517662A5 (cg-RX-API-DMAC10.html) | ||
| WO2008093772A1 (ja) | 経皮または経粘膜投与のためのアジュバントおよびこれを含む医薬製剤 | |
| JP2007152097A (ja) | 両親媒性高分子被膜 | |
| JP2011507838A5 (cg-RX-API-DMAC10.html) | ||
| JP6114612B2 (ja) | 薬剤コート層の水不溶性薬剤の形態型を制御する方法 | |
| WO2007124700A3 (en) | Pharmaceutical composition containing taxane derivative destined for the preparation of an infusion solution, method of preparation thereof and use thereof |